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Abstract Cell adhesion molecules participate in the for-
mation, maturation, function and plasticity of synaptic
connections. The growing body of evidence indicates that
in the regulation of the synaptic plasticity, in which these
molecules play pivotal role, also the proteolytic processes
are involved. This review focuses on extracellular prote-
olysis of the cell adhesion molecules by specific subgroup
of the matrix metalloproteinases, a disintegrin and metal-
loproteases and a disintegrin and metalloproteinase with
thrombospondin motifs, jointly referred to as metzincins, in
driving coordinated synaptic structural and functional
modifications underlying synaptic plasticity in the adult
brain.
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cLTP Chemical long term potentiation
PKC Protein kinase C
MAP kinase Mitogen-activated protein kinase
PI 3-kinase Phosphoinositide 3-kinase
PTZ Pentylenetetrazol
Introduction
After the initial establishment of neuronal connections
during development, synapses remain highly dynamic and
undergo activity-dependent changes in their efficacy and
morphology. Communication between neurons at the syn-
apses is mediated primarily by neurotransmitter release and
by the gating of the postsynaptic receptor ion channels, but
burgeoning evidence indicates that signaling is also medi-
ated by adhesion molecules that interact in a homo- or
heterophilic fashion across the synaptic cleft. Thus, cell
adhesion molecules (CAMs) at the synapse mediate syn-
aptic plasticity, the ability to change synaptic function,
thought to underlie learning and memory, as well as
implicated in a number of neuropsychiatric conditions. It
is, however, still poorly understood how synaptic CAMs
contribute to synapse formation and/or structure, and
whether and/or how smaller groups of CAMs serve as
minimal, functionally cooperative adhesive units upon
which the structure is based [1].
An increasing number of studies support the idea that
structural changes at the synapses are closely associated
with synaptic plasticity. A majority of these dynamic
changes in the synaptic microenvironment are regulated by
various families of proteases, including mainly metzincins
[2] and serine proteases. Their function is to cleave the
proteins available in the extracellular matrix (ECM) and
even to release signaling molecules from ECM and CAMs,
which may play an essential role for changes in synaptic
configuration. Notably, ECM remodeling affects both
structural and functional plasticity, such as long-term
potentiation (LTP), long-term depression (LTD), homeo-
static plasticity, and metaplasticity [3]. Importantly, the
synaptic remodeling involves a complex sequential prote-
olytic activation and interaction of different molecules
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resulting in the control of various processes acting at the
synapse, such as receptors trafficking, cytoskeleton
remodeling, formation, growth and morphological changes
of new and existing dendritic spines. Notably, it has
repeatedly been shown that the same target molecule can
be recognized and processed by various proteases and the
released soluble ectodomains of CAMs may interact with
different ligands, leading to the generation of distinct
signals.
Proteolysis of Cell Adhesion Molecules
At the synapse, cell adhesion molecules operate in syner-
gistic association in the control of adhesive function and
signal transduction by forming dynamic network rather
than acting as independent molecules. Similarly, the pro-
cesses associated with remodeling of neuronal connections
are achieved by the concerted actions of several different
proteases that are secreted by neurons and glial cells [4, 5].
One of the most prominent features between CAMs and
proteases actions is that they are reciprocal. Metzincins are
apparently the major effectors in remodeling the structures
of neuronal circuits which contribute to the fine tuning of
diverse biological processes through limited proteolysis of
specific targets. Recent data strongly imply their important
role in the modulation of morphology of dendritic spines
which lead to changes in signaling pathway and molecules
trafficking in the brain. Table 1 contains summary infor-
mation on cleavage of CAMs by metzincins and the role of
their proteolytic processing in synaptic plasticity.
Cadherins
Among the principal representatives of the CAMs are
cadherins. Members of the cadherin superfamily share
general expression profiles and have distinct functions
during the brain development and in the mature brain
function. Their main role is to tie up the pre- and post-
synaptic part of synapse by homophilic interactions. Inside
the cells, cadherins are bound to the actin cytoskeleton via
b-catenins and affect synaptogenesis, maintenance of cell–
cell contact and dendritic spine morphology [6]. It was
shown that surface population of cadherin molecules is
regulated by proteolytic cleavage in the extracellular
matrix or intracellular milieu. Neuronal cadherin (N-cad-
herin) undergoes the ectodomain cleavage by at least
two membrane-bound matrix metalloproteinases (MMPs),
ADAM10 and membrane type 5-matrix metalloproteinase
(MT5-MMP), followed by the intramembrane proteolysis
mediated by PS1/c-secretase complex [7–10]. ADAM10
plays a crucial role in the complex sequence of events that
regulates dendritic spine maturation and/or stabilization
and in the modulation of the structural organization of the
glutamatergic synapse [7]. The ADAM10 driven process-
ing in response to calcium influx via NMDA type
glutamate receptor is required for the subsequent PS1/c-
secretase cleavage of N-cadherin, which leads to releasing
of a cytoplasmic fragment. This process is called regulated
intramembrane proteolysis (RIP), in which removal of the
ectodomain by shedding is necessary for the second
cleavage catalyzed by c-secretase [11]. The proteolytic
processing of N-cadherin affects the interaction between
N-cadherin and b-catenin, leading to release of b-catenin
from the cell surface and directing it to the nucleus, to
regulate genes involved in the proliferation of neuronal
stem cells, neuronal differentiation, axonal remodeling and
synaptogenesis [9]. It might be suggested that such prote-
olytic modulation of b-catenin interaction with N-cadherin
may be a substantial molecular mechanism for the synaptic
plasticity.
Recently, Gardoni et al. [12] have shown that PACAP38
has an impact on the modulation of dendritic spine
morphology through the ADAM10-N-cadherin-AMPA
receptor signaling pathway. Pituitary adenylate cyclase-
activating polypeptide 38 (PACAP38) is neuropeptide that
is implicated in the induction of the synaptic plasticity at
the excitatory glutamatergic synapse. It has been shown
that PACAP38 induces a form of long-term depression in
the hippocampal neurons and transgenic animals, thus
indicating its role in learning and memory [13–16].
Moreover, PACAP38 leads to a strong increase of
ADAM10 activity through three signaling cascades (PKC,
MAP kinase and PI 3-kinase) [17]. Impairing ADAM10
localization and activity at the synapse decreases its pro-
cessing of N-cadherin. Thus, it induces a modification of
the synaptic AMPA receptors, and a significant increase in
the size of dendritic spines, both in vitro and in vivo [7].
More recently, Warren et al. [18] have shown the dif-
ferences in the expression and distribution of ADAM10,
MT5-MMP and N-cadherin after traumatic brain injury
(TBI), leading to maladaptive synaptic plasticity. MT5-
MMP and ADAM10 are critical to the success of injury-
induced synaptic plasticity. They displayed time-dependent
increases during synaptogenesis, and elevated enzyme
activity was concatenated with a reduction of the synaptic
adhesion protein, N-cadherin.
ADAM10 inhibition contributes to elevated N-cadherin
expression and improves synaptic stability under mal-
adaptive conditions. Sustained N-cadherin expression is
reported to underlie both structural and physiological
plasticity at the synapse [6, 19, 20]. Furthermore, it was
also shown that manipulation of cadherins by either using
specific blocking peptide or antibodies, or genetic muta-
tions lead to disruption of N-cadherin molecule that has a
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profound and long-lasting effect on synaptic plasticity and
memory formation [19, 20]. Moreover, a dysfunction of the
cadherin-based adhesive system may alter functional con-
nectivity and information processing in the human brain in
neuropsychiatric disorders [21].
Notably, the ectodomain shedding of other members of
cadherin family in multiple pathophysiological conditions,
including inflammation and cancer, has been observed. For
instance, it was demonstrated that vascular endothelial
cadherin (VE-cadherin), an endothelial-specific member of
cadherin family, that forms a complex with beta-catenin
and stabilizes cell–cell adhesion is also cleaved by MMP-7
on the cell membrane of the human umbilical vein endo-
thelial cell. This phenomenon might play an important role
in angiogenesis [22]. Moreover, ADAM10-mediated
endothelial cadherin (E-cadherin) proteolysis was proposed
as a regulatory mechanism in inflammatory epidermal
diseases, which are characterized by loss of E-cadherin
expression and loss in epithelial integrity [23]. In breast
cancer, it was observed that upregulation of the ADAM15
leads to enhance cleavage of E-cadherin [24]. In the brain,
during early stage of neural development the presence of
E-cadherin has been observed. It was shown that E-cad-
herin is first expressed in the embryonic ectoderm and
plays a role in maintaining of ectoderm and future epi-
dermis architecture together with other cadherins. Soon
after neural induction, E-cadherin is replaced by N-cad-
herin. So far, however, it has apparently not been shown
that E-cadherin is processed by metzincins in the brain.
Syndecans
Syndecans are a major class of heparin sulfate proteogly-
cans (HSPGs) and are involved in adhesion-induced syn-
aptic modifications. Four members of the syndecan family,
syndecan-1, -2, -3, and -4, have been characterized in the
mammalian tissues, including the brain. For instance,
Table 1 Metzincins implicated in synaptic plasticity and their substrates in the brain
Family Synaptic
substrates
Metzincin cleavage Possible synaptic effects of processing Refs.
Cadherins N-cadherin MT5-MMP, ADAM-10 Proliferation of neuronal stem cells, neuronal
differentiation, axonal remodeling and
synaptogenesis, modulation of dendritic spine
morphology
[7–10]
Syndecans Syndecan-1 MMP-2, -7, -9, MT1-MMP,
MT3-MMP, ADAM-17
Dendritic spine development, cell adhesion,








NCAM MMP-2, ADAMs Neurite branching and outgrowth, influence on
LTP, structural remodeling of neuronal
connections
[37, 38, 46, 47]
L1-CAM ADAM-10, -17 Neurite outgrowth, neuronal differentiation and
migration
[41]
Nectin-1 ADAM-10 Regulation of the spine density and morphology,
cell–cell interaction, influence on LTP and
LTD
[49–51]
SynCAM 1 ADAM-17 Modulation of synaptic interactions [51]
SynCAM 2 MMP-9 Remodeling of dendritic spine structure [56]
ICAM-5 MMP-2, -9 Maturation of dendritic spines, cytoskeleton
reorganization, morphological remodeling of
dendritic spines,
[57, 62, 63]
Dystroglycans b-dystroglycan MMP-9 Cytoskeleton reorganization, modulation of
dendritic spine morphology
[65, 66]
Neurexins b-neurexin MMPs Regulation of the synapse formation and
stabilization of the connectivity in the CNS
[69, 70]
Thrombospon-dins TSP1 MMP-2, ADAMTS1 ND [74–79]
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syndecan-2 plays a prominent role in the organization of
postsynaptic structures. It is highly concentrated on the
spines of mature hippocampal neurons, and plays a critical
role in the dendritic spine development [25]. The other
member, syndecan-3, is involved in cell adhesion, neurite
guidance, and cell migration during development of the
nervous system [26]. Moreover, it has been suggested to
function as an important modulator of the synaptic plas-
ticity that influences hippocampus-dependent memory
[27]. Through interaction with several cytoplasmic pro-
teins, syndecans may provide a molecular link between
intracellular cytoskeleton/signaling complex and the
extracellular environment at specific sites on the cell sur-
face [25].
It has been shown that syndecans undergo regulated
proteolytic shedding from the cell surface. Interestingly,
syndecans are differentially cleaved by three classes of
metzincins: MMPs, a disintegrin and metalloproteases
(ADAMs) and a disintegrin and metalloproteinase with
thrombospondin motifs (ADAMTS) proteases. MMP-2 and
MMP-9 can cleave syndecans-1, -2 and -4 [28, 29]. MMP-7
and membrane-associated metalloproteinases MT1-MMP
and MT3-MMP are known to cleave syndecan-1 [30, 31]. It
has recently been demonstrated that ADAM17 is able to
shed syndecan-1 and syndecan-4 [32], and the latter is also
processed by ADAMTS1 and ADAMTS4 proteases [33].
Moreover, for it has been shown that the remaining portion
of the syndecan-3 can be further processed by the PS1/c-
secretase complex. The multiplicity of proteases able to
cleave syndecans may result from the heterogeneity of their
ectodomains and may depend on the cell type and stimula-
tory conditions. Hence, still is not clear how extracellular
stimuli influence sheddases to mediate syndecan cleavage.
Although, the syndecans cleavage was not demonstrated in
the brain, it cannot be excluded that some of their neuronal
functions may be regulated by proteolysis.
NCAM and L1-CAM
NCAM and L1 are members of immunoglobulin-like
superfamily that were repeatedly implicated in synaptic
functions, as well as neuronal migration, neuronal survival,
neurite outgrowth, myelination, axon guidance, fascicula-
tion, and regeneration [34–36].
Both NCAM and L1 were shown to be processed by
metzincins. Inhibition of NCAM-mediated adhesion with
either function-blocking antibodies or synthetic peptides
did not affect normal basal synaptic transmission, but
reduced E-LTP in area CA1, along with impaired hippo-
campal-dependent learning [37]. Hinkle et al. [38] revealed
that regulated ADAM metalloprotease-induced ectodomain
shedding of NCAM down-regulates neurite branching and
neurite outgrowth in primary cortical neurons.
In vitro and in vivo studies showed that cleavage of L1
protein is elicited by two sheddases ADAM10 and
ADAM17. Both proteases critically affect the physiologi-
cal functions of L1 adhesion protein. Proteases-mediated
disruption of L1-dependent contacts might be an important
mechanism for the regulation of the adhesion of migrating
neurons. Moreover, ADAM10-dependent releasing of sol-
uble L1 ectodomain from cultured neurons promotes neu-
rite outgrowth and influences neuronal differentiation. In
addition, it was shown that NMDA-stimulated Ca2? influx
might be the cause for enhanced ADAM10 activity, leading
to increased L1 shedding. This Ca2? influx is known to
affect activity-dependent synaptic plasticity [39]. Besides,
L1 is also cleaved by PS1/c-secretase complex. This reg-
ulated intramembrane proteolysis process [40], also dem-
onstrated for the N-cadherin or nectin-1, affects signal
transduction at the synapse. Furthermore, Matsumoto-
Miyai et al. [41] found that the plasticity-related L1 is a
specific substrate of neuropsin and that this neuropsin-L1
processing system is regulated by neural activity and is
involved in the hippocampal plasticity.
NCAMs are involved in the initial phase of long-term
potentiation in the hippocampus and learning [42, 43]. It has
been reported that NCAM may be cleaved extracellularly
in vivo in response to the activation of NMDA receptors
during the induction of LTP and in response to seizures [44,
45]. Additionally, Hubschmann et al. [46] have shown that
NCAM can be released from the primary hippocampal
neurons in vitro and this cleavage involves extracellular
ATP and can be inhibited by the metalloproteinase inhibi-
tor. The ATP released either during learning or induction of
LTP may target NCAM for proteolysis, and this proteolysis
is necessary for the structural remodeling of neuronal con-
nections taking place during consolidation of LTP. All these
findings suggest that metalloproteinase activity regulates
NCAM-mediated neurite outgrowth, possibly by cleaving
NCAM from the extending neurite, thereby reducing
adhesion to an immobile environment and thus facilitating
further neurite extension [46]. The members of NCAM
family are also implicated in aberrant plasticity. It was
shown that neural cell adhesion molecules and metzincins,
together play an important role in the pathogenesis of
experimental autoimmune encephalomyelitis (EAE). The
observed elevated level of MMP-2 and impaired expression
of NCAM in the hippocampus appear to be critical for both
the brain plasticity and underlie a complex autoimmune
process in the brain in acute EAE [47].
The expression of the paralog of NCAM, NCAM2 has
been proposed to influence certain types of neurological
diseases and cancers. Both proteins are abundant in the
central nervous system (CNS), suggesting that they also
1116 Neurochem Res (2013) 38:1113–1121
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may share functional similarities. To date, there is no
information about proteolytic cleavage of NCAM2. Nev-
ertheless, it cannot be excluded that in the olfactory system,
where NCAM2 is important for the formation or mainte-
nance of the dendritic and axonal compartmentalization, its
function might be regulated by proteolysis, similarly to
NCAM1 [48].
Nectins
Nectins are Ca2?-independent immunoglobulin-like adhe-
sion molecules, involved in cell–cell adherent junctions.
Nectin-1 ectodomain shedding and intramembrane cleav-
age occurs in postsynaptic as well as presynaptic mem-
branes, where it is localized [49, 50]. Kim et al. [51] have
shown that nectin-1 cleavage plays a role in the regulation
of the spine density. It is well documented that activation of
NMDA receptors or chemical long-term potentiation
(cLTP) result in ADAM10 activation which is one of the
major proteases responsible for ectodomain shedding of
nectin-1 in neurons [49, 51]. The extracellular proteolysis of
nectin-1 generates at least two soluble ectodomains [50].
These protein fragments may act as signaling molecules in
the synaptic cleft by interacting with other ECM compo-
nents and thus regulating cell–cell interaction or may bind
to their receptors, initiating a cascade of signaling inside the
cell. Thus, taken together, these events may influence on
changes in density and spine morphology observed during
induction of LTP and LTD. On the other hand, the intra-
membrane domain of nectin-1 released by activity of
presenilin-dependent gamma-secretase complex may also
serve many roles. The C-terminal fragment of nectin-1 may
be translocated into the nucleus and acts as either tran-
scriptional stimulator or repressor. Sequence analysis
revealed that this intracellular fragment contains a putative
nuclear localization signal (RRRH) right after the trans-
membrane domain [52]. Moreover, cleavage of nectin-1
releases cytoplasmic proteins such as afadin from periphe-
ral membranes and causes its translocation into the nucleus
and thus, may regulate the subcellular localization of afadin
between the plasma membrane and the nucleus [53].
SynCAMs
Synaptic cell adhesion molecules (SynCAMs) belong to the
immunoglobulin-like protein family and act as an adhesion
molecules in the synaptic cleft forming a homo- and het-
erophilic transsynaptic adhesion complexes that contributes
to synapse organization and function [54]. Tanabe et al.
[55] have shown that SynCAM1 can be processed by
ADAM17-like proteases at the synapse. The biological
importance of this phenomenon may be associated with the
modulation of synaptic interaction and plasticity. Recently,
using proteomic approach, the cleavage of SynCAM2 via
MMP-9 has been demonstrated [56]. SynCAM2 cleavage
evoked by MMP-9 might influence the remodeling of the
dendritic spine structure in response to synaptic transmis-
sion. It indicates that different SynCAMs can be cleaved by
various types of proteases, however, the exact mechanism
of this process still remains unknown.
ICAM-5
Tian et al. [57], showed that intercellular adhesion mole-
cule-5 (ICAM-5), protein specifically expressed in post-
natal excitatory neuronal cell bodies, dendritic shafts, and
dendritic filopodia of the telencephalon [58, 59], is a sub-
strate for either MMP-2 or MMP-9. Upon neuronal stim-
ulation, ICAM-5 cleavage driven by MMPs, caused the
dendritic spines maturation and elongation of filopodia.
Moreover, blocking of MMP-2 and MMP-9 by specific
inhibitor as well as ICAM-5 deficiency led to the retraction
of the spine heads and a decreased number of spines in
response to NMDA stimulation [57]. The mechanism of
spine remodeling through MMPs dependent ICAM-5
cleavage has been proposed [60, 61]. In neurons, stimula-
tion of either NMDA or AMPA receptors for glutamate
leads to enhancement of MMP-2 and MMP-9 activity,
resulting in processing of ICAM-5 from immature nascent
spines. The shedding of ICAM-5 may facilitate local
membrane and cytoskeleton reorganization, and thereby
morphological remodeling of the dendritic spines [57]. In
addition, recent results have shown that ICAM-5 can be
also cleaved by exogenous MMP-3 and MMP-7, in
response to neuronal activation by either NMDA treatment
or induction of LTP [62].
Furthermore, it was shown that soluble ICAM-5 is
generated with cLTP. The N-terminal domain of ICAM-5
is able to stimulate integrin dependent actin polymerization
within dendrites, and thus spine expansion. In addition, the
inhibition of MMPs activity and blocking of b1 integrins
diminished ICAM-5 dependent effects. Overall, these
findings indicate that MMPs and soluble ICAM-5 have the
potential to influence neuronal excitability [63].
b-Dystroglycan
Dystroglycan is a part of dystrophin-glycoprotein complex
that links dystrophin and the intracellular cytoskeleton with
extracellular matrix and anchors the whole complex at the
membrane [64]. DG is composed of a- and b-subunits.
a-dystroglycan (a-DG) is a highly glycosylated extracellular
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component, whereas b-DG spans the plasma membrane
forming a bridge between a-DG and the cytoskeleton [65].
Michaluk et al. [66] have shown that MMP-9 driven b-DG
proteolysis occurs in response to synaptic activity in neuronal
cultures and in the hippocampus in response to seizures.
Simultaneously, in neurons, after treatment with specific
inhibitor (TIMP-1) blocking MMP-9 activity and in MMP-9
knockout mice, the appearance of truncated form of the
protein was not observed. So far, the exact consequences of
b-dystroglycan cleavage are not known, however, a growing
body of evidence suggests a functional role for the entire
dystrophin-glycoprotein complex at central synapses and in
their plasticity. For instance, it was shown that mice selec-
tively deficient in the brain dystroglycan suffer from late
phase of long term potentiation deficits in the hippocampus
[65]. Moreover, mutations in the genes encoding dystrogly-
can-binding proteins such as laminin, its extracellular ligand,
as well as dystrophin, are associated with mental retardation.
Notably, specific changes in the hippocampal expression
patterns of transcripts encoding dystrophin and neurexins,
presynaptic interacting partners of DG, following kainate and
PTZ treatment in vivo have been previously demonstrated
[67, 68].
b-Neurexin
It was also established that cell surface adhesion receptors
undergo proteolytic cleavage in the synaptic cleft. Among
them, it was shown that biological role ofb-neurexin is closely
associated with its proteolytic processing. The presynaptic
receptors neurexins (NRXs), and their ligands, postsynaptic
neuroligins (NLs) are two families of synapse-specific adhe-
sion molecules critically involved in regulation of the synapse
formation and stabilization of the connectivity in the central
nervous system. It was demonstrated that mutations in neu-
rexins may lead to synaptic defects associated with brain
disorders (e.g. mental retardation, autism). Studies by several
independent groups have shown that neurexins can be pro-
teolytically processed at the synapse [69, 70]. Thus, both
in vitro and in vivo neurexins are sequentially cleaved by
metalloprotease- and PS1/c-secretase dependent activities.
In neurons, accumulated N- and C-terminal fragments of
b-neurexin play a dual role, as signaling molecule in the
extracellular milieu as well as in the intracellular space.
Thrombospondins
Thrombospondins (TSPs) are involved in cell–cell inter-
actions and synaptogenesis and have the ability to bind to
the matrix proteins, proteinases, growth factors, and cell
surface receptors. Recently, it was shown that thrombo-
spondin 1 and thrombospondin 2 promote synaptogenesis,
both in vitro and in vivo, and their deficiency results in
reduced synaptic density during development [71]. More-
over, both of them are involved in modulation of the
synaptic plasticity and axonal sprouting after ischemic
injury [72]. However, one of the best described roles of
TSP1 is action as an anti-angiogenic agent. TSPs functions
have been well established in cancer biology where angi-
ogenesis is essential for tumor growth [73].
To date, many reports indicate that TSPs are processed
by various proteases in extracellular matrix. It was shown
that ADAMTSs are involved in the processing of extra-
cellular glycoproteins, including TSP1 and TSP2 [74]. For
instance, cleavage of TSP1 and TSP2 by ADAMTS1 could
modulate their functions by facilitate remodeling of matrix-
associated TSP [75]. Furthermore, most recently, the global
proteomic studies discovered that TSPs are also targets for
other metzincins. Hence, thrombospondin-1 and thrombo-
spondin-2 are MMP-2 [76] and MMP-14 [77] substrates,
respectively. Moreover, for thrombospondin-2 the cleavage
by MMP-2 and MMP-9 was confirmed [78]. TSP5 was also
shown to be proteolytically processed by different MMPs
in vitro [79]. Nevertheless, despite the established role of
TSPs in the brain, especially during synaptogenesis, so far,
there is no direct data about the regulation of these proteins
by proteolysis.
Future Directions
Interest in the identification of proteodegradome in the
extracellular matrix, including discovering of the new tar-
gets for proteases and understanding their function, has
intensified in recent years in a hope to increase our
knowledge of the synaptic machinery. In this review, we
emphasize that cell adhesion molecules play not only
scaffolding role in the synaptic cleft, but foremost are
capable to modulate the functional and structural aspects of
the synaptic plasticity in both normal and pathological
conditions. It has to be noted that presented list of CAMs
which undergo proteolytic turnover at the synapse is still
open. Completion of genome sequences for many organ-
isms allows to protein classification into the respective
clusters. Based on individual protein domain structures for
extracellular matrix proteins the ECM and adhesion pro-
teins, the concepts of ‘‘matrisome’’ and ‘‘adhesome’’ have
been implemented [75, 76]. This opens a window for
classification of new ECM and ECM-associated proteins as
important in regulation of the synaptic plasticity and
understanding how these components can influence neu-
ronal network dynamics.
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